NCT02266563View on ClinicalTrials.gov

Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 21, 2017

Study Completion Date

December 21, 2017

Conditions

Traumatic Brain InjuryChronic Traumatic EncephalopathyMild Cognitive Impairment

Interventions

DRUG

Amyvid PET Scan

A thin line will be inserted into a vein in one arm for the injection of the tracer. Subjects will begin the Amyvid PET scan 50-60 minutes after the injection of the tracer, and scanned for about 20 minutes.

DRUG

T807 PET scan

Scanning will begin 80 minutes after the injection of the tracer, and last for about 20 minutes.

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors

lead

Samuel Gandy

OTHER

NCT02266563 - Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury | Biotech Hunter | Biotech Hunter